Signal transduction pathways associated with ATP-induced proliferation of colon adenocarcinoma cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 9, 2010, Pages 946-955

  Buzzi, Natalia ^a   Boland, Ricardo ^a   Russo de Boland, Ana ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

ATP; Caco 2 cell; Proliferation; Signal transduction

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 1; ACTIVATING TRANSCRIPTION FACTOR 2; ADENOSINE TRIPHOSPHATE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN C FOS; PROTEIN C JUN; PURINERGIC P2Y RECEPTOR; UO 126; DUSP1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PURINERGIC P2 RECEPTOR; PURINERGIC P2 RECEPTOR AGONIST; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CACO 2 CELL LINE; COLON TUMOR; DRUG EFFECTS; GENETICS; METABOLISM;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; CACO-2 CELLS; CELL PROLIFERATION; COLONIC NEOPLASMS; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM PROTEINS; PROTEIN KINASE INHIBITORS; PURINERGIC P2 RECEPTOR AGONISTS; RECEPTORS, PURINERGIC P2; TRANSCRIPTION FACTORS;

EID: 77955280923     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.05.009     Document Type: Article

References (66)

1. Thevananther S., Sun H., Li D., et al. Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 2004, 39:393-402.
2. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
3. Heo S.J., Han H.J. ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways. Stem Cells 2006, 24:2637-2648.
4. Chang S.J., Tzeng C.H.R., Lee Y.H., Tai C.H.J. Extracellular ATP activates the PLC/PKC/ERK signaling pathway through the P2Y2 purinergic receptor leading to the induction of early growth response 1 expression and the inhibition of viability in human endometrial stromal cells. Cell. Signal. 2008, 20:1248-1255.
5. Buzzi N., Scodelaro Bilbao P., Boland R., Russo de Boland A. Extracellular ATP 478 activates MAP kinase cascades through a P2Y purinergic receptor in the human 479 intestinal Caco-2 cell line. Biochim. Biophys. Acta 2009, 1709:1651-1659.
6. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50:413-492.
7. Burnstock G. Purinergic signalling. Br. J. Pharmacol. 2006, 147:S172-S181.
8. Hollopeter G., Jantzen H.M., Vincent D., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409:202-207.
9. Marteau F., Le Poul E., Communi D., et al. Pharmacological characterization of the human P2Y13 receptor. Mol. Pharmacol. 2003, 64:104-112.
10. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 1995, 9:726-735.
11. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-3112.
12. Farooq A., Zhou M.M. Structure and regulation of MAPK phosphatases. Cell. Signal. 2004, 16:769-779.
13. Coutinho-Silva R., Stahl L., Cheung K.K., et al. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:1024-1035.
14. Höpfner M., Maaser K., Barthel B., et al. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int. J. Colorectal Dis. 2001, 16:154-166.
15. Bradford M. A rapid and sensitive method for quantification of microgram quantities of proteins utilizing the principle of protein binding. Anal. Biochem. 1976, 72:248-254.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970, 227:680-685.
17. Hill C.S., Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995, 80:199-211.
18. Karin M., Hunter T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 1995, 5:747-757.
19. Ballif B.A., Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 2001, 12:397-408.
20. Cuenda A., Rouse J., Doza Y.N., et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
21. Bennett B.L., Sasaki D.T., Murray B.W., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
22. Loda M., Capodieci P., Mishra R., et al. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am. J. Pathol. 1996, 149:1553-1564.
23. Zhang L., Zhou W., Velculescu V.E., et al. Gene expression profiles in normal and cancer cells. Science 1997, 276:1268-1272.
24. Brondello J.M., Brunet A., Pouysségur J., McKenzie F.R. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 1997, 272:1368-1376.
25. Sanchez-Tillo E., Comalada M., Xaus J., et al. JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation. J. Biol. Chem. 2007, 282:12566-12573.
26. Aliaga J.C., Deschênes C., Beaulieu J.-F., Calvo E.L., Rivard N. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 1999, 277:631-641.
27. Buzzi N., Colicheo A., Boland R., Russo de Boland A. MAP kinases in proliferating human colon cancer Caco-2-cells. Mol. Cell. Biochem. 2009, 328:201-208.
28. Ghanem E., Robaye B., Leal T., et al. The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretion. Br. J. Pharmacol. 2005, 146:364-369.
29. Matos J.E., Sorensen M.V., Geyti C.S., Robaye B., Boeynaems J.M., Leipziger J. Distal colonic Na(+) absorption inhibited by luminal P2Y(2) receptors. Pflugers. Arch. 2007, 454:977-987.
30. Degagné E., Grbic D.M., Dupuis A.A., et al. P2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells. J. Immunol. 2009, 183:4521-4529.
31. Matos J.E., Robaye B., Boeynaems J.M., Beauwens R., Leipziger J. K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon. J. Physiol. 2005, 564:269-279.
32. Burnstock G. Pathophysiology and therapeutic potential of purinergic signalling. Pharmacol. Rev. 2006, 58:58-86.
33. Vachon P.H., Harnois C., Grenier A., et al. Differentiation state-selective roles of p38 isoforms in human intestinal epithelial cell anoikis. Gatroenterology 2002, 123:1980-1991.
34. Lee J.K., Park J., Lee Y.D., Lee S.H., Han P.L. Distinct localization of SAPK isoforms in neurons of adult mouse brain implies multiple signaling modes of SAPK pathway. Mol. Brain Res. 1999, 70:116-124.
35. Pena E., Berciano M.T., Fernandez R., Crespo P., Lafarga M. Stress-induced activation of c-Jun N-Terminal kinase in sensory ganglion neurons: accumulation in nuclear domains enriched in splicing factors and distribution in perichromatin fibrils. Exp. Cell Res. 2000, 256:179-191.
36. Ben-Levy R., Hooper S., Wilson R., Paterson H.F., Marshall C.H.J. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr. Biol. 1998, 8:1049-1057.
37. Raingeaud J., Gupta S., Rogers J.S., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995, 270:7420-7426.
38. Zehorai E., Yao Z., Plotnikov A., Seger R. The subcellular localization of MEK and ERK-a novel nuclear traslocation signal (NTS) paves a way to the nucleus. Mol. Cell. Endocrinol. 2010, 314:213-220.
39. Blanco-Aparicio C., Torres J., Pulido R. A novel regulatory mechanism of MAP Kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J. Cell Biol. 1999, 147:1129-1135.
40. Mizukami Y., Yoshioka K., Morimotoi S., Yoshida K. A novel mechanism of JNK1 activation Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J. Biol. Chem. 1997, 272:16657-16662.
41. van Dam H., Castellazzi M. Distinct roles of Jun:Fos and Jun:ATF dimmers in oncogenesis. Oncogene 2001, 20:2453-2464.
42. Kallunki T., Deng T., Hibi M., Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 1996, 87:929-939.
43. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003, 22:3876-3886.
44. Stocco C.O., Lau L.F., Gibori G. A calcium/calmodulin-dependent activation of ERK1/2 mediates JunD phosphorylation and induction of nur77 and 20alpha-hsd genes by prostaglandin F2alpha in ovarian cancer. J. Biol. Chem. 2002, 277:3293-3302.
45. Yazgan O., Pfarr C.M. Regulation of two JunD isoforms by Jun N-terminal kinases. J. Biol. Chem. 2002, 277:29710-29718.
46. Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20:2438-2452.
47. Wang H., Birkenbach M., Hart J. Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis 2000, 21:1313-1317.
48. Neary J.T., Abbracchio M.P. Trophic roles of purines and pyrimidines. Handbook of Experimental Pharmacology: Purinergic and Pyrimidergic Signalling 2000, Springer-Verlag, New York. M. Williams, M.P. Abbracchio (Eds.).
49. Elia M.G., Muscella A., Romano S., et al. Effects of extracellular nucleotides in the thyroid: P2Y2 receptor-mediated ERK1/2 activation and c-Fos induction in PC Cl3 cells. Cell. Signal. 2005, 17:739-749.
50. Muscella A., Elia M.G., Greco S., Storelli C., Marsigliante S. Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J. Cell. Physiol. 2003, 195:234-240.
51. Janknecht R., Ernst W.H., Pingoud V., Nordheim A. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 1993, 12:5097-5104.
52. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 1996, 16:1247-1255.
53. Hongxing Z., Nancai Y., Wen S., et al. Depletion of c-Myc inhibits human colon cancer colo 320 cells' growth. Cancer Biother. Radiopharm. 2008, 23:229-237.
54. Keyse S.M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008, 27:253-261.
55. Small G.W., Somasundaram S., Moore D.T., Shi Y.Y., Orlowski R.Z. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK. JPET 2003, 307:861-869.
56. Orlowski R.Z., Small G.W., Shi Y.Y. Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitormediated apoptosis. J. Biol. Chem. 2002, 277:27864-27871.
57. Brondello J.M., Pouysségur J., McKenzie F.R. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 1999, 286:2514-2517.
58. Lee Y.J., Han H.J. Role of ATP in DNA synthesis of renal proximal tubule cells: involvement of calcium, MAPKs, and CDKs. Am. J. Physiol. Ren. Physiol. 2006, 291:98-106.
59. Heo J.S., Han H.J. ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways. Stem Cells 2006, 24:2637-2648.
60. Hou M., Moller S., Edvinsson L., Erlinge D. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2064-2069.
61. Greig A.V., Linge C., Healy V., et al. Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J. Invest. Dermatol. 2003, 121:315-327.
62. Maaser K., Hopfner M., Kap H., et al. Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br. J. Cancer 2002, 86:636-644.
63. Zheng J.S., Boluyt M.O., Long X., O'Neill L., Lakatta E.G., Crow M.Y. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ. Res. 1996, 78:525-535.
64. Zheng J.S., O'Neill L., Long X., et al. Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts. Cardiovasc. Res. 1998, 37:718-728.
65. Huwiler A., Wartmann M., van den Bosch H., Pfeilschifter J. Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells. Br. J. Pharmacol. 2000, 129:612-618.
66. Vonend O., Grote T., Oberhauser V., Von Kugelgen I., Rump L.C. P2Y receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway. Br. J. Pharmacol. 2003, 139:1119-1126.